Chapter 24. DNA Topoisomerases as Therapeutic Targets in Cancer Chemotherapy
- 1 January 1986
- book chapter
- Published by Elsevier
- Vol. 21, 257-262
- https://doi.org/10.1016/s0065-7743(08)61134-3
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Chromosomol DNA fragments from mouse cells exposed to an intercalating agent contain a 175-kdalton terminal polypeptideCanadian Journal of Biochemistry and Cell Biology, 1985
- In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatinCell, 1985
- Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26Biochemical and Biophysical Research Communications, 1984
- Epidermal growth factor-induced topoisomerase(s)Experimental Cell Research, 1983
- DNA topoisomerasesCell, 1980
- Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand breakCell, 1980
- The Biology of Oxygen RadicalsScience, 1978
- Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino)methanesulfonanilidesJournal of Medicinal Chemistry, 1976
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974
- Potential antitumor agents. 11. 9-AnilinoacridinesJournal of Medicinal Chemistry, 1971